To investigate the effectiveness of micro-RNA-371a-3p as a biomarker for predicting recurrence in clinical stage I testicular cancer.
Utilized micro-RNA-371a-3p measurement
Analyzed recurrence rates in clinical stage I testicular cancer patients
Employed statistical analysis to assess predictive accuracy.
Micro-RNA-371a-3p was significantly associated with recurrence risk in patients (specific metrics not provided).
Higher levels of micro-RNA-371a-3p correlated with increased recurrence rates, indicating its potential as a predictive biomarker.
Abstract
Richard S Matulewicz, Andrea Knezevic, Adam Levin, Fei Ye, Darren R Feldman, Samuel A Funt; Utilizing Micro-RNA-371a-3p for Recurrence Prediction in Clinic